Sensex
78,151.45 profit arw 964.58 (1.25%)
Nifty
24,334.30 profit arw 261.55 (1.09%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below
As on : 18-Jul-2026
USFDA inspects Cipla subsidiary's manufacturing unit in New York
 <P>Cipla announced that an inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of the company) located in Central Islip, Long Island, New York, USA, from 13 July 2026 to 17 July 2026 (EDT). </P> <P>The inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. On conclusion of the inspection, the company has received 1 (one) inspectional observation in Form 483. </P>

INDIAN INDICES

Sensex

78,151.45 964.58 (1.25%)

Nifty

24,334.30 261.55 (1.09%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

24,562.25 -446.36(-1.78%)